The 1st China Pharmaceutical Innovation Conference (CPIC), hosted by TONACEA, will be grandly held from July 22 to 24, 2026, at the National Exhibition and Convention Center (Shanghai).

Benchmarking the J.P. Morgan Healthcare Conference, CPIC aims to establish a new paradigm of "Chinese Innovation – Global Translation – Shanghai Transaction." As the "premier window" for global capital and enterprises to gain insight into China's innovation ecosystem, and as the "core hub" for Chinese pharmaceutical companies to upgrade, go global, and connect with the world, CPIC is set to become the definitive barometer for annual investment and collaboration in the global health industry. The conference will feature dozens of dedicated sessions covering numerous hot topics and future directions in health industry innovation investment and globalization.

The birth of a logo often marks the beginning of a brand story. From concept to final design, after multiple rounds of refinement, this logo carries all our expectations for this grand event. It is not just a symbol, but a visual declaration of China's innovative drugs stepping onto the world stage. This July in Shanghai, let us gather under this logo and embark on the journey of China Pharmaceutical Innovation.

Scan the QR code to register now!
Limited-time early bird tickets at 40% off – grab yours now!!
The overseas registration link will be available soon. Stay tuned!

Conference Logo

The inaugural China Pharmaceutical Innovation Conference (CPIC) will be held from July 22 to 24, 2026, at the National Exhibition and Convention Center (Shanghai). Preparations are now in full swing. The conference organizing committee has officially released the conference logo.

The logo is built on a DNA double helix design, incorporating the CPIC letter mark and a diverse, international color palette. It encapsulates the conference theme – "China Innovation for Global Healthcare" – and reflects TONACEA's two-decade commitment to pharmaceutical innovation and its mission to connect global resources.

Foundation of Science, Core of Industry: The DNA double helix anchors the scientific essence of biomedicine, symbolizing the core development genes of China's innovative drug industry. The helix spirals upward and outward, depicting the rapid rise of China's biopharmaceutical sector and the vibrant energy of biomedicine as a national emerging pillar industry.

Global Connectivity, Mutual Prosperity: The diverse, interwoven colors along the DNA chain convey CPIC's international positioning, symbolizing deep connectivity, open collaboration, and shared prosperity between China and the global pharmaceutical industry. The upward, extended chain naturally integrates TONACEA's free-spirited and dynamic character, blending the industry symbol with the organizer's imprint, signifying that global pharmaceutical innovation resources are closely linked through CPIC.

Exclusive Identity, Future Vision: The prominent CPIC letter mark gives the logo a distinctive identity, serving as a visual symbol that brings together multinational pharmaceutical companies, local biotechs, investment institutions, and other key stakeholders in Shanghai. The overall design integrates professional industry attributes, momentum for takeoff, global connectivity, and a sense of home ground, conveying the vision of "Building CPIC Together, Shaping the Future of Global Innovative Drugs" – letting Chinese innovation truly achieve global healthcare.